Dalbak, Ellen Thea Gjelseth
Væringstad, Anette
Lichtwarck, Bjørn
Myhre, Janne
Holle, Daniela
Bergh, Sverre
Kirkevold, Øyvind https://orcid.org/0000-0001-5698-5636
Funding for this research was provided by:
Sykehuset Innlandet HF (150 668)
NTNU Norwegian University of Science and Technology
Article History
Received: 20 December 2023
Accepted: 10 May 2025
First Online: 28 May 2025
Declarations
:
: The present study has been approved by the Data Protection Official at Innlandet Hospital Trust (case number: 23928741), and it has been submitted to the Data Protection Official of the included municipalities. In case of significant protocol modifications, a notification of the changes will be forwarded to the Data Protection Officer at Innlandet Hospital Trust. The main part of the process evaluation will involve health professionals and health administrators, and we will follow standard regulations for privacy and data protection. The questionnaire distributed to the staff in the home care services will be deidentified with an identification number to maintain their anonymity and facilitate high response rate and honest answers. Regarding data collection for the cost evaluation, patients and their next of kin who are invited to participate will be asked to give their written consent. The project team from the home care services will perform an assessment of the capacity to provide consent and obtain consent. For patients considered to lack the capacity to consent, the next of kin can consent on the patient’s behalf. The collected data from the patients will be deidentified. All data collected from staff, patients and their next of kin will be stored on a secured research server at Innlandet Hospital Trust. Data will be stored for 5 years after the end of the project for control reasons. The participant-level dataset and statistical code will only be accessible to the central research team and will not be available to others. In the effectiveness study, care and treatment actions will rely on national treatment guidelines and care, and no experimental treatments for patients will be introduced in the effectiveness study.
: The consent form for staff in the municipalities is provided in the appendices. By completing the attached questionnaire, staff in the municipalities consent to participate in the study. The consent form for the focus group interviews is also attached as appendix. These consent forms will have the same content but will be tailored to the role (TIME administrations, GPs, manager of the home care service, care staff) the participant has had in the study. The version of the consent forms presented to participants is in Norwegian, an English translation is included in the appendix.
: The authors declare that they have no competing interests.